The global advanced wound care market size is expected to reach USD 14.87 billion by 2030, expanding at a CAGR of 4.75% from 2024 to 2030, according to a new report by Grand View Research, Inc. Growth in the number of the aging population as well as an increasing figure of diabetic patients are some major factors driving this market’s growth.
For instance, as per a United Health Foundation report (published in May 2023), more than 55.8 million adults aged 65 and older lived in the U.S., accounting for about 16.8% of the nation's population in 2021, increasing the number of senior populations is anticipated to propel the market during the forecast period.
There has been growth in the number of surgical procedures, and traumatic incidents globally. For instance, as per a study by Research Gate, in 2022, around 6.6% of mortality occurs due to trauma every year. Similarly, there has been an increase in the number of surgical site infections. Advanced wound care products help to contain and reduce these surgical site infections, thereby, an increase in the number of surgical site infections is expected to drive the market during the forecast period.
The introduction of the COVID-19 vaccine, and the lifting of lockdown impositions, are expected to have a positive impact on the market over the forecast period. Many elective surgeries, which were postponed, are expected to take place. In addition to this, many leading manufacturers are introducing new products which may help them to capitalize on the increasing demand for advanced wound care products during the forecast period.
Request a free sample copy or view report summary: Advanced Wound Care Market Report
Based on product, the moist wound care segment led the market with the largest revenue share of 70.88% in 2023. This dominance can be attributed to an increase in a number of wound cases and increase in number of surgeries globally.
In terms of application, the chronic wounds segment is dominate the market with the largest revenue share in 2023. Increasing number of diabetic foot ulcers, venous pressure ulcers, and other chronic wounds is expected to drive the segment growth.
Based on end-use, the hospital segment held the market with the largest revenue share of 45.31% in 2023. The growth of this segment can be attributed to the upsurge in surgical procedures and increase in the number of hospital admissions.
North America dominated the market with the revenue share of 45.46% in 2023. This dominance can be attributed to well-developed healthcare infrastructure and increase in the number of surgical procedures.
Asia Pacific is anticipated to witness significant CAGR during the forecast period. This can be attributed to the presence of major key players, the increasing prevalence of chronic disorders, and rising healthcare expenditure.
Grand View Research has segmented the global advanced wound care market based on product, application, end use, and region:
Advanced Wound Care Product Outlook (Revenue, USD Million, 2018 - 2030)
Moist
Foam Dressings
Hydrocolloid Dressings
Film Dressings
Alginate Dressings
Hydrogel Dressings
Collagen Dressings
Other Advanced Dressings
Antimicrobial
Silver
Non-silver
Active
Biomaterials
Skin-substitute
Growth Factors
Advanced Wound Care Application Outlook (Revenue, USD Million, 2018 - 2030)
Chronic Wounds
Diabetic Foot Ulcers
Pressure Ulcers
Venous Leg Ulcers
Other Chronic Wounds
Acute Wounds
Surgical & Traumatic Wounds
Burns
Advanced Wound Care End Use Outlook (Revenue, USD Million, 2018 - 2030)
Hospitals
Specialty Clinics
Home Healthcare
Others
Advanced Wound Care Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
China
Japan
India
South Korea
Australia
Thailand
Latin America
Brazil
Argentina
MEA
South Africa
Saudi Arabia
UAE
Kuwait
List of Key Players in Advanced Wound Care Market
ConvaTec Group PLC
Smith & Nephew PLC
Mölnlycke Health Care AB
B. Braun Melsungen AG
3M
URGO
Coloplast Corp.
Integra LifeSciences
Medline Industries, Inc.
"The quality of research they have done for us has been excellent..."